MENOTROPINS

MENOTROPINS was reported 2221 times

MENOTROPINS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHOLANGIOSARCOMA 3 0.3750
1 DELAYED FOLLICULAR RIPENING 1 0.3333
2 OVARIAN HYPERSTIMULATION SYNDROME 434 0.1860
3 POOR RESPONSE TO OVULATION INDUCTION 2 0.1818
4 MALIGNANT HYDATIDIFORM MOLE 1 0.1667
5 PREMATURE OVULATION 12 0.1538
6 HETEROTOPIC PREGNANCY 9 0.1429
7 PROTEIN S ABNORMAL 2 0.1429
8 HERMAPHRODITISM 1 0.1111
9 OVARIAN NECROSIS 7 0.1111
10 GONADAL DYSGENESIS 1 0.1000
11 CYSTOSARCOMA PHYLLODES 1 0.1000
12 OVARIAN TORSION 8 0.0964
13 THROMBIN-ANTITHROMBIN III COMPLEX INCREASED 2 0.0952
14 HOFFMANN'S SIGN 1 0.0909
15 OPTIC NERVE SHEATH MENINGIOMA 2 0.0909
16 MULTIPLE PREGNANCY 16 0.0894
17 VAGINAL CUFF DEHISCENCE 2 0.0667
18 OMENTUM NEOPLASM 1 0.0667
19 FAILED IN VITRO FERTILISATION 4 0.0656
20 PREGNANCY OF UNKNOWN LOCATION 1 0.0588
21 CORNEAL LIGHT REFLEX TEST ABNORMAL 1 0.0588
22 HAEMOCONCENTRATION 10 0.0578
23 CLEAR CELL ENDOMETRIAL CARCINOMA 1 0.0556
24 OOCYTE HARVEST 1 0.0526
25 INTRACRANIAL ARTERY DISSECTION 1 0.0526
26 DIMINISHED OVARIAN RESERVE 1 0.0526
27 OVARIAN HAEMORRHAGE 12 0.0506
28 HUMAN CHORIONIC GONADOTROPIN NEGATIVE 1 0.0476
29 URETEROCELE 2 0.0465
30 OESTRADIOL ABNORMAL 3 0.0455
31 BLOOD GONADOTROPHIN INCREASED 1 0.0400
32 MEDICAL OBSERVATION ABNORMAL 1 0.0385
33 BLOOD HUMAN CHORIONIC GONADOTROPIN DECREASED 1 0.0357
34 OVARIAN CYST TORSION 2 0.0339
35 HEPATOBLASTOMA 3 0.0309
36 CONJOINED TWINS 3 0.0303
37 CONGENITAL HEPATOBILIARY ANOMALY 1 0.0294
38 OBSTETRIC PROCEDURE COMPLICATION 1 0.0270
39 PELVIC PERITONEAL ADHESIONS 1 0.0263
40 BLOOD OESTROGEN INCREASED 15 0.0255
41 OVARIAN ENLARGEMENT 9 0.0234
42 PROGESTERONE ABNORMAL 1 0.0222
43 POLYMICROGYRIA 1 0.0222
44 PELVIC FLUID COLLECTION 15 0.0213
45 BLOOD VISCOSITY ABNORMAL 2 0.0211
46 ABORTION SPONTANEOUS INCOMPLETE 2 0.0206
47 CONGENITAL GENITAL MALFORMATION FEMALE 1 0.0204
48 PRADER-WILLI SYNDROME 1 0.0196
49 TRISOMY 13 2 0.0196
50 MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY-ASSOCIATED DISEASE 3 0.0195
51 ANOVULATORY CYCLE 4 0.0193
52 ADNEXAL TORSION 6 0.0189
53 BREAST INJURY 3 0.0184
54 BASILAR ARTERY OCCLUSION 3 0.0181
55 ABORTION THREATENED 9 0.0181
56 HUMAN CHORIONIC GONADOTROPIN POSITIVE 1 0.0175
57 HUMAN CHORIONIC GONADOTROPIN ABNORMAL 1 0.0172
58 CIRCULATORY FAILURE NEONATAL 1 0.0169
59 NATURAL KILLER CELL COUNT INCREASED 1 0.0167
60 IN VITRO FERTILISATION 3 0.0166
61 TUBO-OVARIAN ABSCESS 4 0.0164
62 UMBILICAL CORD PROLAPSE 2 0.0163
63 BLOOD LUTEINISING HORMONE INCREASED 4 0.0163
64 DUODENAL ATRESIA 2 0.0163
65 NIPPLE ENLARGEMENT 1 0.0161
66 ECTOPIC PREGNANCY TERMINATION 1 0.0159
67 BLOOD FOLLICLE STIMULATING HORMONE ABNORMAL 1 0.0154
68 GARDNERELLA INFECTION 1 0.0145
69 ENDOTOXIC SHOCK 1 0.0145
70 CARDIAC PSEUDOANEURYSM 1 0.0145
71 OCULOAURICULOVERTEBRAL DYSPLASIA 1 0.0139
72 TWIN PREGNANCY 11 0.0131
73 OVARIAN DISORDER 12 0.0128
74 HAEMORRHAGIC OVARIAN CYST 7 0.0122
75 ENCEPHALOCELE 3 0.0120
76 ABDOMINAL WALL ANOMALY 1 0.0112
77 EXCESSIVE EXERCISE 1 0.0105
78 HAEMORRHAGIC ASCITES 3 0.0105
79 FIBRIN DEGRADATION PRODUCTS INCREASED 3 0.0101
80 PERFORMANCE ENHANCING PRODUCT USE 1 0.0101
81 CEPHALO-PELVIC DISPROPORTION 2 0.0100
82 OESTRADIOL INCREASED 3 0.0100
83 DRUG EXPOSURE BEFORE PREGNANCY 10 0.0099
84 FOETAL MOVEMENTS DECREASED 1 0.0098
85 PRODUCT ADMINISTRATION ISSUE 2 0.0096
86 OVARIAN FAILURE 5 0.0093
87 BIOCHEMICAL PREGNANCY 1 0.0093
88 PLACENTA ACCRETA 2 0.0092
89 ECTOPIC PREGNANCY 28 0.0091
90 PELVIC HAEMATOMA 4 0.0091
91 BENIGN HYDATIDIFORM MOLE 3 0.0091
92 CRANIOPHARYNGIOMA 3 0.0090
93 OVARIAN RUPTURE 1 0.0085
94 OVULATION DISORDER 1 0.0085
95 PELVIC ADHESIONS 2 0.0084
96 LACRIMATION DISORDER 1 0.0082
97 INTESTINAL MALROTATION 2 0.0076
98 ANTITHROMBIN III DECREASED 2 0.0073
99 EFFUSION 10 0.0073
100 CHROMOSOME ABNORMALITY 1 0.0072
101 BONE FISSURE 3 0.0072
102 FORCED EXPIRATORY VOLUME ABNORMAL 1 0.0069
103 NEONATAL RESPIRATORY ARREST 1 0.0068
104 FALLOPIAN TUBE DISORDER 2 0.0068
105 CONGENITAL SCOLIOSIS 1 0.0066
106 PERITONEAL HAEMORRHAGE 9 0.0065
107 RENAL ARTERY THROMBOSIS 2 0.0065
108 OVARIAN ABSCESS 1 0.0064
109 PREGNANCY INDUCED HYPERTENSION 1 0.0062
110 OESTRADIOL DECREASED 2 0.0062
111 MALIGNANT MELANOMA STAGE II 1 0.0061
112 MENSTRUATION NORMAL 2 0.0060
113 OVARIAN ADENOMA 1 0.0060
114 FOETAL CHROMOSOME ABNORMALITY 1 0.0059
115 MATERNAL EXPOSURE BEFORE PREGNANCY 40 0.0058
116 GENITALIA EXTERNAL AMBIGUOUS 1 0.0058
117 ANAEMIA OF PREGNANCY 1 0.0058
118 HAEMATOCRIT INCREASED 13 0.0057
119 PUNCTURE SITE HAEMORRHAGE 4 0.0056
120 BLOOD LUTEINISING HORMONE DECREASED 1 0.0056
121 BASILAR ARTERY THROMBOSIS 1 0.0056
122 HYDROMETRA 1 0.0054
123 ADMINISTRATION SITE DISCOMFORT 1 0.0053
124 INJECTION SITE ECZEMA 1 0.0052
125 RENAL DYSPLASIA 2 0.0052
126 RUPTURED ECTOPIC PREGNANCY 4 0.0052
127 BLIGHTED OVUM 2 0.0051
128 PROLACTIN-PRODUCING PITUITARY TUMOUR 1 0.0051
129 NECROTISING ENTEROCOLITIS NEONATAL 2 0.0049
130 ANTEPARTUM HAEMORRHAGE 2 0.0048
131 OPTIC DISC DISORDER 1 0.0048
132 BACTERIA URINE IDENTIFIED 1 0.0047
133 FEMALE REPRODUCTIVE TRACT DISORDER 1 0.0046
134 PELVIC HAEMORRHAGE 1 0.0046
135 CYST RUPTURE 3 0.0044
136 ABORTION 12 0.0041
137 TENSION 25 0.0041
138 NEONATAL RESPIRATORY FAILURE 2 0.0040
139 CONGENITAL HYDROCEPHALUS 2 0.0039
140 ABORTION MISSED 5 0.0039
141 OVARIAN NEOPLASM 3 0.0039
142 JUGULAR VEIN THROMBOSIS 7 0.0039
143 CEREBRAL CALCIFICATION 1 0.0037
144 INTRA-UTERINE DEATH 6 0.0037
145 AMAUROSIS 3 0.0036
146 CARDIO-RESPIRATORY DISTRESS 1 0.0035
147 ACUTE ABDOMEN 5 0.0034
148 HUMAN CHORIONIC GONADOTROPIN INCREASED 3 0.0033
149 ASCITES 95 0.0032
150 PROGESTERONE DECREASED 1 0.0032
151 OESOPHAGEAL ATRESIA 2 0.0032
152 ALOPECIA TOTALIS 1 0.0030
153 COAGULATION TIME SHORTENED 1 0.0030
154 DRUG EFFECT FASTER THAN EXPECTED 1 0.0030
155 WAIST CIRCUMFERENCE INCREASED 3 0.0029
156 FEEDING DISORDER NEONATAL 3 0.0029
157 BLOOD OESTROGEN DECREASED 2 0.0028
158 GRANULOMATOUS LIVER DISEASE 2 0.0028
159 TUMOUR NECROSIS 3 0.0028
160 CERVIX DISORDER 2 0.0028
161 AMNIOTIC CAVITY INFECTION 2 0.0028
162 RENAL INFARCT 4 0.0028
163 ABSCESS BACTERIAL 1 0.0028
164 PRODUCT COMPOUNDING QUALITY ISSUE 1 0.0027
165 CYTOGENETIC ABNORMALITY 3 0.0027
166 HYPEREMESIS GRAVIDARUM 1 0.0026
167 POLYCYSTIC OVARIAN SYNDROME 1 0.0026
168 MACROCEPHALY 1 0.0026
169 BREAST FEEDING 2 0.0026
170 BLOOD FOLLICLE STIMULATING HORMONE INCREASED 1 0.0026
171 PREGNANCY TEST POSITIVE 1 0.0025
172 INTRA-ABDOMINAL HAEMORRHAGE 6 0.0025
173 PREMATURE RUPTURE OF MEMBRANES 6 0.0025
174 BRONCHOPULMONARY DYSPLASIA 2 0.0025
175 ENDOMETRIAL DISORDER 1 0.0024
176 ARTERY DISSECTION 1 0.0024
177 INVASIVE BREAST CARCINOMA 1 0.0024
178 HYPOCAPNIA 1 0.0024
179 GENE MUTATION IDENTIFICATION TEST POSITIVE 1 0.0024
180 GASTRODUODENAL ULCER 1 0.0024
181 PYLORIC STENOSIS 2 0.0024
182 ADNEXA UTERI PAIN 3 0.0023
183 CHOROIDAL NEOVASCULARISATION 2 0.0023
184 CONGENITAL MUSCULOSKELETAL ANOMALY 1 0.0023
185 OLIGURIA 14 0.0023
186 BIOPSY BONE MARROW ABNORMAL 1 0.0022
187 SUSPECTED PRODUCT QUALITY ISSUE 4 0.0022
188 PREMENSTRUAL SYNDROME 3 0.0022
189 PREGNANCY TEST FALSE POSITIVE 1 0.0021
190 DYSPHASIA 1 0.0021
191 NEUROLOGICAL EXAMINATION ABNORMAL 1 0.0021
192 THERAPEUTIC RESPONSE INCREASED 2 0.0021
193 HYPERCOAGULATION 4 0.0021
194 MORPHOEA 1 0.0021
195 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 1 0.0021
196 CERVICAL INCOMPETENCE 1 0.0020
197 CEREBRAL ARTERY THROMBOSIS 1 0.0019
198 UTERINE CONTRACTIONS DURING PREGNANCY 2 0.0019
199 POSTURING 1 0.0019
200 HYPOPERFUSION 2 0.0019
201 ABDOMINAL DISTENSION 198 0.0019
202 NEUROGENIC SHOCK 1 0.0018
203 MORNING SICKNESS 1 0.0018
204 SUBCLAVIAN VEIN THROMBOSIS 2 0.0018
205 ADMINISTRATION SITE PAIN 2 0.0017
206 ABORTION SPONTANEOUS 69 0.0017
207 LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR 1 0.0017
208 CEREBRAL VENOUS THROMBOSIS 3 0.0017
209 NIPPLE DISORDER 1 0.0016
210 ADENOCARCINOMA OF COLON 3 0.0016
211 BREECH PRESENTATION 2 0.0016
212 TRISOMY 21 2 0.0016
213 LARYNGEAL DISCOMFORT 1 0.0016
214 APGAR SCORE LOW 2 0.0016
215 BREAST ENLARGEMENT 5 0.0015
216 OVARIAN CYST 15 0.0015
217 COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS 1 0.0015
218 CAESAREAN SECTION 17 0.0015
219 DEATH NEONATAL 2 0.0014
220 CHRONIC FATIGUE SYNDROME 2 0.0014
221 MATERNAL DRUGS AFFECTING FOETUS 11 0.0014
222 PRODUCT DESIGN ISSUE 1 0.0014
223 DRUG LEVEL DECREASED 14 0.0014
224 HEMIANOPIA HOMONYMOUS 1 0.0014
225 FOETAL DEATH 7 0.0013
226 BRAIN HERNIATION 4 0.0013
227 INFERTILITY 2 0.0013
228 DRUG EXPOSURE DURING PREGNANCY 45 0.0013
229 PREGNANCY 26 0.0013
230 MYELITIS 2 0.0013
231 POLYCYSTIC OVARIES 2 0.0013
232 UTERINE DISORDER 3 0.0013
233 HYPOTONIA NEONATAL 2 0.0013
234 FOETAL GROWTH RETARDATION 1 0.0013
235 BLOOD FIBRINOGEN INCREASED 1 0.0013
236 LIMB MALFORMATION 1 0.0013
237 OVARIAN CANCER RECURRENT 2 0.0012
238 ENDOMETRIAL HYPERPLASIA 1 0.0012
239 COVID-19 IMMUNISATION 1 0.0012
240 LIP PRURITUS 1 0.0012
241 PATERNAL EXPOSURE DURING PREGNANCY 1 0.0012
242 EOSINOPHILIC PNEUMONIA ACUTE 1 0.0012
243 ABSCESS DRAINAGE 1 0.0012
244 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 81 0.0011
245 PRODUCT RECONSTITUTION QUALITY ISSUE 1 0.0011
246 UTERINE POLYP 2 0.0011
247 IMPLANT SITE PRURITUS 1 0.0011
248 MUSCLE NECROSIS 1 0.0011
249 RED BLOOD CELL COUNT INCREASED 3 0.0011
250 EXTENSOR PLANTAR RESPONSE 1 0.0011
251 FOETAL HEART RATE ABNORMAL 1 0.0011
252 PUPILLARY REFLEX IMPAIRED 2 0.0011
253 MENINGIOMA BENIGN 1 0.0011
254 ADVERSE FOOD REACTION 1 0.0011
255 ABORTION INCOMPLETE 2 0.0011
256 PROTEIN TOTAL DECREASED 4 0.0011
257 ABORTION INDUCED 10 0.0011
258 PELVIC DISCOMFORT 1 0.0011
259 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
260 URINE OUTPUT DECREASED 9 0.0010
261 CONTINUOUS HAEMODIAFILTRATION 1 0.0010
262 DUST ALLERGY 1 0.0010
263 HAEMOPHILUS INFECTION 1 0.0010
264 HEMIANOPIA 1 0.0010
265 ANTISOCIAL BEHAVIOUR 1 0.0010
266 ACQUIRED HAEMOPHILIA 1 0.0010
267 THYROIDITIS 3 0.0010
268 BENIGN BREAST NEOPLASM 1 0.0010
269 GASTRIC PH DECREASED 1 0.0010
270 DEMYELINATION 4 0.0010
271 CAPILLARY LEAK SYNDROME 2 0.0010
272 INJECTION SITE HYPERSENSITIVITY 3 0.0010
273 NON-CARDIOGENIC PULMONARY OEDEMA 1 0.0009
274 LANGUAGE DISORDER 2 0.0009
275 ACINETOBACTER INFECTION 1 0.0009
276 CEREBELLAR SYNDROME 2 0.0009
277 GENERALISED TONIC-CLONIC SEIZURE 15 0.0009
278 POOR QUALITY DEVICE USED 9 0.0009
279 CLEFT LIP AND PALATE 1 0.0009
280 CRYPTORCHISM 1 0.0009
281 PREMATURE LABOUR 5 0.0009
282 OESTROGEN RECEPTOR ASSAY POSITIVE 1 0.0009
283 LIGAMENT INJURY 1 0.0009
284 ERYTHEMA NODOSUM 3 0.0009
285 FIBRIN D DIMER INCREASED 3 0.0008
286 GESTATIONAL DIABETES 4 0.0008
287 RECALLED PRODUCT ADMINISTERED 8 0.0008
288 ASTHMATIC CRISIS 3 0.0008
289 CEREBRAL ARTERY EMBOLISM 1 0.0008
290 UTERINE LEIOMYOMA 6 0.0008
291 EYE OEDEMA 2 0.0008
292 PALATAL OEDEMA 1 0.0008
293 BLOOD UREA DECREASED 1 0.0008
294 OVARIAN CYST RUPTURED 1 0.0008
295 IATROGENIC INJURY 1 0.0008
296 PANIC DISORDER 3 0.0008
297 BREAST SWELLING 2 0.0007
298 ECHOCARDIOGRAM ABNORMAL 1 0.0007
299 PRERENAL FAILURE 1 0.0007
300 INJECTION SITE IRRITATION 9 0.0007
301 PRECANCEROUS CELLS PRESENT 1 0.0007
302 UTERINE HAEMORRHAGE 3 0.0007
303 GENITAL RASH 1 0.0007
304 INJECTION SITE HYPOAESTHESIA 1 0.0007
305 PELVIC VENOUS THROMBOSIS 1 0.0007
306 MULTIPLE CONGENITAL ABNORMALITIES 1 0.0007
307 DYSPNOEA AT REST 2 0.0007
308 ESCHERICHIA SEPSIS 2 0.0007
309 ABDOMINAL PAIN LOWER 17 0.0007
310 BLOOD CULTURE POSITIVE 2 0.0007
311 ADHESION 1 0.0007
312 HAEMOGLOBIN INCREASED 3 0.0007
313 NEEDLE ISSUE 19 0.0007
314 INTRACARDIAC THROMBUS 2 0.0007
315 INJECTION SITE PARAESTHESIA 1 0.0007
316 INFERTILITY FEMALE 1 0.0006
317 PRODUCT DEPOSIT 1 0.0006
318 BACTERIAL VAGINOSIS 1 0.0006
319 PHARYNGEAL PARAESTHESIA 1 0.0006
320 ORTHOPNOEA 2 0.0006
321 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1 0.0006
322 ANTIPHOSPHOLIPID SYNDROME 1 0.0006
323 HEPATITIS ACUTE 4 0.0006
324 CARDIOVASCULAR INSUFFICIENCY 1 0.0006
325 PRODUCT PREPARATION ISSUE 4 0.0006
326 MATERNAL EXPOSURE DURING PREGNANCY 54 0.0006
327 PELVIC PAIN 11 0.0006
328 ANTIBODY TEST POSITIVE 1 0.0006
329 GAZE PALSY 1 0.0006
330 INJECTION SITE RASH 18 0.0006
331 INJECTION SITE OEDEMA 1 0.0006
332 APLASIA PURE RED CELL 2 0.0006
333 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
334 LACK OF INJECTION SITE ROTATION 1 0.0006
335 INJECTION SITE DISCOMFORT 6 0.0006
336 ALOPECIA AREATA 1 0.0006
337 NEONATAL RESPIRATORY DISTRESS SYNDROME 2 0.0006
338 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
339 FAECALOMA 3 0.0005
340 THROMBOCYTOSIS 2 0.0005
341 INTERMENSTRUAL BLEEDING 3 0.0005
342 RETINOPATHY 2 0.0005
343 HYDRONEPHROSIS 4 0.0005
344 MATERNAL EXPOSURE TIMING UNSPECIFIED 2 0.0005
345 BREAST TENDERNESS 4 0.0005
346 NARCOLEPSY 1 0.0005
347 PLEURAL EFFUSION 32 0.0005
348 OESOPHAGEAL ULCER 2 0.0005
349 MOTION SICKNESS 1 0.0005
350 CONVERSION DISORDER 1 0.0005
351 HYPOALBUMINAEMIA 4 0.0005
352 HYPERTRIGLYCERIDAEMIA 3 0.0005
353 PATENT DUCTUS ARTERIOSUS 2 0.0005
354 MUCOSAL DRYNESS 1 0.0005
355 ABDOMINAL PAIN 115 0.0005
356 INJECTION SITE PAIN 151 0.0005
357 NIPPLE PAIN 1 0.0005
358 CEREBRAL INFARCTION 12 0.0005
359 SUBARACHNOID HAEMORRHAGE 5 0.0005
360 POLYCYTHAEMIA 1 0.0005
361 HYPOSPADIAS 1 0.0005
362 INJECTION SITE PRURITUS 32 0.0005
363 DILATATION VENTRICULAR 1 0.0005
364 OPTIC NEUROPATHY 1 0.0005
365 EAR SWELLING 1 0.0005
366 PREMATURE BABY 14 0.0005
367 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
368 JAW FRACTURE 1 0.0005
369 FACIAL PALSY 1 0.0005
370 BIPOLAR I DISORDER 1 0.0005
371 ENDOMETRIAL CANCER 1 0.0005
372 VULVOVAGINAL DISCOMFORT 2 0.0005
373 INJECTION SITE BRUISING 36 0.0005
374 ORAL PRURITUS 1 0.0004
375 OVARIAN CANCER 4 0.0004
376 CHEST DISCOMFORT 44 0.0004
377 MASS 6 0.0004
378 DYSMORPHISM 1 0.0004
379 METASTASIS 3 0.0004
380 MYOPIA 1 0.0004
381 HYPOVOLAEMIC SHOCK 2 0.0004
382 STILLBIRTH 2 0.0004
383 ENTEROCOCCAL INFECTION 2 0.0004
384 HORMONE LEVEL ABNORMAL 2 0.0004
385 PHARYNGEAL SWELLING 4 0.0004
386 ABDOMINAL TENDERNESS 2 0.0004
387 INJECTION SITE ABSCESS 1 0.0004
388 PERSECUTORY DELUSION 1 0.0004
389 LACTOSE INTOLERANCE 1 0.0004
390 HEPATOSPLENOMEGALY 1 0.0004
391 PLATELET COUNT INCREASED 5 0.0004
392 COMPARTMENT SYNDROME 1 0.0004
393 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
394 AFFECTIVE DISORDER 3 0.0004
395 GASTRITIS 10 0.0004
396 POOR QUALITY PRODUCT ADMINISTERED 4 0.0004
397 INJECTION SITE MASS 14 0.0004
398 INJECTION SITE REACTION 26 0.0004
399 PROTEIN TOTAL INCREASED 1 0.0004
400 VAGINAL HAEMORRHAGE 16 0.0004
401 HYDROCEPHALUS 2 0.0004
402 ABNORMAL FAECES 3 0.0004
403 CLONUS 1 0.0004
404 ESCHERICHIA INFECTION 3 0.0004
405 DEAFNESS UNILATERAL 2 0.0004
406 MENSTRUAL DISORDER 3 0.0004
407 EMBOLISM 3 0.0004
408 EOSINOPHILIC OESOPHAGITIS 1 0.0004
409 INTRACRANIAL PRESSURE INCREASED 2 0.0004
410 ANAL HAEMORRHAGE 1 0.0004
411 DISSEMINATED INTRAVASCULAR COAGULATION 5 0.0004
412 CHOLECYSTITIS ACUTE 2 0.0004
413 INJECTION SITE SCAR 1 0.0004
414 HOT FLUSH 26 0.0003
415 HAEMOTHORAX 1 0.0003
416 TYPE 1 DIABETES MELLITUS 2 0.0003
417 CEREBROVASCULAR DISORDER 1 0.0003
418 CENTRAL VENOUS CATHETERISATION 1 0.0003
419 CRANIOCEREBRAL INJURY 1 0.0003
420 KERATITIS 1 0.0003
421 MASTICATION DISORDER 1 0.0003
422 DYSAESTHESIA 1 0.0003
423 INJECTION SITE URTICARIA 8 0.0003
424 BRAIN DEATH 1 0.0003
425 CYST 4 0.0003
426 INJECTION SITE DISCOLOURATION 4 0.0003
427 ASPARTATE AMINOTRANSFERASE INCREASED 17 0.0003
428 INJECTION SITE ERYTHEMA 39 0.0003
429 BILE DUCT STONE 1 0.0003
430 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
431 MYDRIASIS 4 0.0003
432 PANCREATITIS ACUTE 7 0.0003
433 PROCTALGIA 2 0.0003
434 GENITAL HAEMORRHAGE 4 0.0003
435 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
436 OTITIS MEDIA 1 0.0003
437 VAGINAL DISCHARGE 3 0.0003
438 HEPATIC CYST 1 0.0003
439 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
440 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
441 EXPOSURE DURING PREGNANCY 18 0.0003
442 HAIR GROWTH ABNORMAL 2 0.0003
443 VENTRICULAR EXTRASYSTOLES 3 0.0003
444 POLYMENORRHOEA 1 0.0003
445 TENDERNESS 3 0.0003
446 HYPERREFLEXIA 1 0.0003
447 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
448 MOOD SWINGS 9 0.0003
449 HEPATOCELLULAR INJURY 4 0.0003
450 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
451 BREAST PAIN 3 0.0003
452 HYPERTHYROIDISM 4 0.0003
453 CAROTID ARTERY OCCLUSION 1 0.0003
454 HYPOMANIA 1 0.0003
455 BLINDNESS TRANSIENT 2 0.0003
456 BURNING SENSATION 19 0.0003
457 CARDIAC DYSFUNCTION 1 0.0003
458 NEURODERMATITIS 1 0.0003
459 PULMONARY MASS 4 0.0003
460 BLOOD SODIUM DECREASED 5 0.0003
461 AUTOIMMUNE THYROIDITIS 1 0.0003
462 ALANINE AMINOTRANSFERASE INCREASED 16 0.0003
463 CARDIOPULMONARY FAILURE 1 0.0003
464 MULTIPLE ALLERGIES 2 0.0003
465 OESOPHAGEAL PAIN 1 0.0003
466 BLOOD ALBUMIN DECREASED 2 0.0003
467 LOW BIRTH WEIGHT BABY 2 0.0003
468 EXPOSURE VIA BREAST MILK 1 0.0003
469 HYPERPHAGIA 1 0.0003
470 MUSCLE HAEMORRHAGE 1 0.0002
471 HYPONATRAEMIA 14 0.0002
472 BURSITIS 3 0.0002
473 HOMICIDAL IDEATION 1 0.0002
474 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
475 PERIPHERAL VENOUS DISEASE 1 0.0002
476 GOITRE 1 0.0002
477 ARTHRITIS BACTERIAL 1 0.0002
478 HYPERAESTHESIA 2 0.0002
479 MANIA 4 0.0002
480 VENTRICULAR TACHYCARDIA 4 0.0002
481 PERITONITIS 5 0.0002
482 BREAST CANCER STAGE II 2 0.0002
483 LIVE BIRTH 2 0.0002
484 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
485 CIRCULATORY COLLAPSE 4 0.0002
486 POOR PERIPHERAL CIRCULATION 1 0.0002
487 ABSCESS LIMB 1 0.0002
488 RETCHING 5 0.0002
489 PRODUCT CONTAINER ISSUE 2 0.0002
490 SKIN HYPERPIGMENTATION 2 0.0002
491 CHAPPED LIPS 1 0.0002
492 INCORRECT DOSE ADMINISTERED BY DEVICE 6 0.0002
493 LIGAMENT RUPTURE 1 0.0002
494 RESPIRATORY RATE INCREASED 2 0.0002
495 HEADACHE 141 0.0002
496 TRANSAMINASES INCREASED 5 0.0002
497 GASTROINTESTINAL INFECTION 2 0.0002
498 PAPILLOEDEMA 1 0.0002
499 LEUKOCYTOSIS 4 0.0002
500 TACHYPNOEA 3 0.0002
501 PALLOR 6 0.0002
502 OPTIC NEURITIS 2 0.0002
503 ACUTE HEPATIC FAILURE 3 0.0002
504 HIDRADENITIS 2 0.0002
505 INJECTION SITE PAPULE 1 0.0002
506 DISEASE COMPLICATION 1 0.0002
507 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
508 ISCHAEMIA 1 0.0002
509 CHRONIC MYELOID LEUKAEMIA 1 0.0002
510 LOCALISED OEDEMA 1 0.0002
511 LACERATION 2 0.0002
512 LEUKAEMIA 2 0.0002
513 PRODUCT PACKAGING ISSUE 2 0.0002
514 LIP SWELLING 7 0.0002
515 ENDOMETRIOSIS 1 0.0002
516 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
517 AFFECT LABILITY 2 0.0002
518 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7 0.0002
519 ANOSMIA 3 0.0002
520 THERAPY NON-RESPONDER 9 0.0002
521 KLEBSIELLA INFECTION 1 0.0002
522 OSTEOPENIA 3 0.0002
523 PHARYNGEAL OEDEMA 3 0.0002
524 ENDOCARDITIS 1 0.0002
525 PRODUCT PREPARATION ERROR 4 0.0002
526 CEREBRAL ISCHAEMIA 1 0.0002
527 MENINGIOMA 3 0.0002
528 PETECHIAE 2 0.0002
529 PRODUCT QUALITY ISSUE 26 0.0002
530 PARTIAL SEIZURES 1 0.0002
531 CATATONIA 1 0.0002
532 ULCER 3 0.0002
533 PREMATURE DELIVERY 3 0.0002
534 NYSTAGMUS 1 0.0002
535 HYPOTHYROIDISM 6 0.0002
536 HEPATIC FUNCTION ABNORMAL 7 0.0002
537 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
538 FOOD POISONING 1 0.0002
539 BLOOD BILIRUBIN INCREASED 5 0.0002
540 NORMAL NEWBORN 1 0.0002
541 SKIN LACERATION 2 0.0002
542 ASTHENOPIA 1 0.0002
543 AUTISM SPECTRUM DISORDER 1 0.0002
544 NECROSIS 1 0.0002
545 HYPERTONIA 1 0.0002
546 SHOCK 4 0.0002
547 HYPERVENTILATION 1 0.0002
548 POST PROCEDURAL HAEMORRHAGE 2 0.0002
549 HYPOVOLAEMIA 1 0.0002
550 SYNCOPE 17 0.0002
551 NAUSEA 133 0.0002
552 IRRITABILITY 10 0.0002
553 INJECTION SITE VESICLES 1 0.0002
554 FOETAL GROWTH RESTRICTION 1 0.0002
555 INGUINAL HERNIA 1 0.0002
556 NO THERAPEUTIC RESPONSE 2 0.0002
557 ACCIDENTAL OVERDOSE 6 0.0002
558 MENISCUS INJURY 1 0.0002
559 LARYNGEAL OEDEMA 1 0.0002
560 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
561 GENERALISED OEDEMA 2 0.0002
562 PRE-EXISTING CONDITION IMPROVED 1 0.0002
563 INFUSION SITE SWELLING 1 0.0002
564 BRAIN OEDEMA 2 0.0002
565 TACHYCARDIA 14 0.0002
566 POST PROCEDURAL COMPLICATION 3 0.0002
567 POOR QUALITY DRUG ADMINISTERED 1 0.0002
568 DIPLOPIA 4 0.0002
569 DEEP VEIN THROMBOSIS 10 0.0002
570 PALPITATIONS 18 0.0002
571 MENORRHAGIA 3 0.0002
572 POLYP 1 0.0002
573 ANKYLOSING SPONDYLITIS 2 0.0002
574 PRODUCT FORMULATION ISSUE 1 0.0002
575 DYSMENORRHOEA 2 0.0002
576 MENINGITIS 1 0.0001
577 SPINAL FRACTURE 3 0.0001
578 POST-TRAUMATIC STRESS DISORDER 1 0.0001
579 PRODUCT ADMINISTRATION ERROR 3 0.0001
580 THERAPEUTIC RESPONSE DECREASED 9 0.0001
581 DYSPNOEA 84 0.0001
582 METASTASES TO LYMPH NODES 1 0.0001
583 DISCOMFORT 9 0.0001
584 PRODUCT LABEL ISSUE 1 0.0001
585 MOOD ALTERED 4 0.0001
586 BLOOD TESTOSTERONE DECREASED 1 0.0001
587 PRODUCT USE IN UNAPPROVED INDICATION 36 0.0001
588 JOINT EFFUSION 1 0.0001
589 ENCEPHALITIS 1 0.0001
590 APHONIA 2 0.0001
591 EXTRASYSTOLES 1 0.0001
592 HALLUCINATION, VISUAL 3 0.0001
593 FEAR OF INJECTION 1 0.0001
594 BREAST CANCER 13 0.0001
595 POOR QUALITY SLEEP 3 0.0001
596 SWELLING 13 0.0001
597 PARAESTHESIA ORAL 2 0.0001
598 PANIC REACTION 1 0.0001
599 DRUG INEFFECTIVE 178 0.0001
600 FEELING DRUNK 1 0.0001
601 HYPOAESTHESIA ORAL 2 0.0001
602 URTICARIA 22 0.0001
603 FEELING HOT 8 0.0001
604 PERICARDIAL EFFUSION 3 0.0001
605 VOMITING 61 0.0001
606 CONGENITAL ANOMALY 1 0.0001
607 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
608 PRODUCT USE COMPLAINT 2 0.0001
609 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
610 HALLUCINATION, AUDITORY 2 0.0001
611 ATRIAL FLUTTER 1 0.0001
612 BLOOD DISORDER 1 0.0001
613 CONTUSION 12 0.0001
614 NIGHT SWEATS 4 0.0001
615 MUSCLE TIGHTNESS 2 0.0001
616 FIBROMYALGIA 3 0.0001
617 PRESYNCOPE 3 0.0001
618 FOETAL EXPOSURE DURING PREGNANCY 10 0.0001
619 ASPHYXIA 1 0.0001
620 POLYURIA 1 0.0001
621 HICCUPS 1 0.0001
622 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
623 AGEUSIA 3 0.0001
624 HEMIPLEGIA 1 0.0001
625 FUNGAL INFECTION 4 0.0001
626 URINARY RETENTION 4 0.0001
627 HAEMODIALYSIS 1 0.0001
628 CARDIOVASCULAR DISORDER 3 0.0001
629 HEMIPARESIS 2 0.0001
630 FLUID RETENTION 6 0.0001
631 INJECTION SITE SWELLING 9 0.0001
632 MUSCULOSKELETAL DISCOMFORT 2 0.0001
633 DEVICE DEFECTIVE 2 0.0001
634 DELIRIUM 4 0.0001
635 NAIL DISORDER 1 0.0001
636 SYRINGE ISSUE 2 0.0001
637 GROIN PAIN 1 0.0001
638 COLD SWEAT 2 0.0001
639 PRODUCT COMMUNICATION ISSUE 1 0.0001
640 INJECTION SITE HAEMORRHAGE 9 0.0001
641 BREAST CANCER FEMALE 3 0.0001
642 ISCHAEMIC STROKE 2 0.0001
643 HAEMARTHROSIS 1 0.0001
644 DEVELOPMENTAL DELAY 1 0.0001
645 CRYING 4 0.0001
646 PATHOGEN RESISTANCE 1 0.0001
647 MUSCLE SPASMS 20 0.0001
648 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
649 DYSURIA 4 0.0001
650 BACTERIAL INFECTION 2 0.0001
651 COMA 5 0.0001
652 SLEEP APNOEA SYNDROME 2 0.0001
653 RASH ERYTHEMATOUS 5 0.0001
654 ACUTE RESPIRATORY FAILURE 2 0.0001
655 ATELECTASIS 1 0.0001
656 RASH 45 0.0001
657 HEPATIC ENZYME INCREASED 7 0.0001
658 SURGERY 6 0.0001
659 DIZZINESS 51 0.0001
660 MULTIPLE SCLEROSIS RELAPSE 7 0.0001
661 HEPATOMEGALY 1 0.0001
662 LABORATORY TEST ABNORMAL 3 0.0001
663 PSYCHOTIC DISORDER 3 0.0001
664 LOSS OF CONSCIOUSNESS 13 0.0001
665 HAEMATOCRIT DECREASED 2 0.0001
666 DEVICE MALFUNCTION 7 0.0001
667 APHASIA 3 0.0001
668 PRODUCT PHYSICAL ISSUE 2 0.0001
669 PRURITUS 38 0.0001
670 HYPOTHERMIA 1 0.0001
671 EAR DISCOMFORT 1 0.0001
672 EMOTIONAL DISORDER 3 0.0001
673 HYPERBILIRUBINAEMIA 1 0.0001
674 ABDOMINAL DISCOMFORT 16 0.0001
675 DERMATITIS ATOPIC 5 0.0001
676 INCONTINENCE 1 0.0001
677 DRUG INTERACTION 15 0.0001
678 MIGRAINE 9 0.0001
679 FATIGUE 73 0.0001
680 DECREASED ACTIVITY 1 0.0001
681 LACTIC ACIDOSIS 3 0.0001
682 PRODUCT DISPENSING ERROR 2 0.0001
683 STAPHYLOCOCCAL INFECTION 3 0.0001
684 INJECTION SITE NODULE 1 0.0001
685 NEOPLASM MALIGNANT 6 0.0001
686 PULMONARY OEDEMA 4 0.0001
687 FLATULENCE 5 0.0001
688 PRODUCT AVAILABILITY ISSUE 2 0.0001
689 MICTURITION URGENCY 1 0.0001
690 NEOPLASM 1 0.0001
691 ADVERSE EVENT 8 0.0001
692 METASTASES TO LUNG 1 0.0001
693 NEOPLASM PROGRESSION 3 0.0001
694 HYPERSENSITIVITY 16 0.0001
695 MADAROSIS 1 0.0001
696 HAEMORRHAGE 9 0.0001
697 ELECTROLYTE IMBALANCE 1 0.0001
698 EYELID OEDEMA 1 0.0001
699 CONDITION AGGRAVATED 26 0.0001
700 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
701 INCORRECT ROUTE OF DRUG ADMINISTRATION 3 0.0001
702 MUSCLE RIGIDITY 1 0.0001
703 PANIC ATTACK 3 0.0001
704 MUSCLE SPASTICITY 1 0.0001
705 DYSPEPSIA 8 0.0001
706 INJECTION SITE EXTRAVASATION 1 0.0001
707 EYE SWELLING 3 0.0001
708 HAIR COLOUR CHANGES 1 0.0001
709 DERMATITIS ALLERGIC 1 0.0001
710 HYPOPHAGIA 2 0.0001
711 CONSTIPATION 17 0.0001
712 ANAPHYLACTIC SHOCK 2 0.0001
713 HIATUS HERNIA 1 0.0001
714 RASH GENERALISED 2 0.0001
715 INJECTION SITE INDURATION 1 0.0001
716 ASTHENIA 29 0.0001
717 NODULE 1 0.0001
718 SPEECH DISORDER 4 0.0001
719 INCORRECT PRODUCT STORAGE 1 0.0001
720 IMMUNE SYSTEM DISORDER 1 0.0001
721 ADVERSE REACTION 1 0.0001
722 BLOOD PRESSURE DECREASED 5 0.0001
723 EYE HAEMORRHAGE 1 0.0001
724 HAIR TEXTURE ABNORMAL 1 0.0001
725 MALIGNANT MELANOMA 1 0.0001
726 JAUNDICE 2 0.0001
727 FREQUENT BOWEL MOVEMENTS 2 0.0001
728 LIMB INJURY 2 0.0001
729 HYPOAESTHESIA 11 0.0001
730 INFLUENZA LIKE ILLNESS 6 0.0001
731 PERIPHERAL COLDNESS 1 0.0001
732 ANAPHYLACTIC REACTION 4 0.0001
733 MEDICATION ERROR 4 0.0001
734 HUNGER 1 0.0001
735 CARDIO-RESPIRATORY ARREST 3 0.0001
736 WEIGHT INCREASED 16 0.0001
737 BLOOD TEST ABNORMAL 1 0.0001
738 SLEEP DISORDER 5 0.0001
739 OSTEOARTHRITIS 3 0.0001
740 RENAL FAILURE ACUTE 3 0.0001
741 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
742 MUSCULAR WEAKNESS 8 0.0001
743 INTENTIONAL DOSE OMISSION 2 0.0001
744 INJECTION SITE HAEMATOMA 1 0.0001
745 LIVER FUNCTION TEST ABNORMAL 2 0.0001
746 FLUID OVERLOAD 1 0.0001
747 RESPIRATORY FAILURE 5 0.0001
748 BONE PAIN 4 0.0001
749 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
750 CHILLS 8 0.0001
751 RESPIRATORY DISORDER 2 0.0001
752 JOINT SWELLING 8 0.0001
753 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
754 ILL-DEFINED DISORDER 4 0.0001
755 SKIN IRRITATION 3 0.0001
756 DRUG DISPENSING ERROR 1 0.0001
757 EPILEPSY 2 0.0001
758 INSURANCE ISSUE 1 0.0001
759 LYMPHOMA 1 0.0001
760 MUSCULOSKELETAL CHEST PAIN 1 0.0001
761 DELUSION 1 0.0001
762 NERVOUS SYSTEM DISORDER 2 0.0001
763 PYREXIA 22 0.0001
764 PARAESTHESIA 10 0.0001
765 ARRHYTHMIA 3 0.0001
766 ABDOMINAL PAIN UPPER 13 0.0001
767 PNEUMOTHORAX 1 0.0001
768 MULTIPLE SCLEROSIS 3 0.0001
769 ABSCESS 1 0.0001
770 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
771 INCORRECT DOSE ADMINISTERED 14 0.0001
772 MULTIPLE FRACTURES 1 0.0001
773 DEVICE DIFFICULT TO USE 4 0.0001
774 TREATMENT FAILURE 5 0.0001
775 VISUAL ACUITY REDUCED 2 0.0001
776 EXPIRED PRODUCT ADMINISTERED 2 0.0001
777 COAGULOPATHY 1 0.0001
778 GAIT INABILITY 2 0.0001
779 ANXIETY 17 0.0001
780 EYE PRURITUS 2 0.0001
781 PERICARDITIS 1 0.0001
782 FACE OEDEMA 1 0.0001
783 METRORRHAGIA 1 0.0001
784 THERAPY CESSATION 3 0.0001
785 FEELING ABNORMAL 14 0.0001
786 MULTI-ORGAN FAILURE 1 0.0001
787 ORTHOSTATIC HYPOTENSION 1 0.0001
788 ECZEMA 3 0.0001
789 LOCAL SWELLING 1 0.0001
790 RASH MACULAR 2 0.0001
791 DEVICE USE ISSUE 1 0.0001
792 PRODUCT STORAGE ERROR 5 0.0001
793 AMENORRHOEA 1 0.0001
794 DEPRESSED MOOD 3 0.0001
795 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
796 HEAD DISCOMFORT 1 0.0001
797 GALLBLADDER DISORDER 1 0.0001
798 C-REACTIVE PROTEIN INCREASED 2 0.0001
799 UNDERDOSE 4 0.0001
800 SOMNOLENCE 11 0.0001
801 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
802 HEPATIC STEATOSIS 1 0.0001
803 NECK PAIN 3 0.0001
804 DYSPNOEA EXERTIONAL 2 0.0001
805 ASTHMA 6 0.0001
806 ACNE 4 0.0001
807 FOOT FRACTURE 1 0.0001
808 PULMONARY EMBOLISM 5 0.0001
809 MALAISE 23 0.0001
810 ANAEMIA 10 0.0001
811 PAIN 32 0.0001
812 PRESCRIBED OVERDOSE 1 0.0001
813 HAEMORRHOIDS 1 0.0001
814 CHOKING 1 0.0001
815 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
816 HEART RATE INCREASED 5 0.0001
817 PRESCRIBED UNDERDOSE 1 0.0001
818 HYPOTENSION 10 0.0000
819 EXTRA DOSE ADMINISTERED 2 0.0000
820 BONE MARROW FAILURE 1 0.0000
821 INJURY ASSOCIATED WITH DEVICE 1 0.0000
822 BODY TEMPERATURE INCREASED 1 0.0000
823 INSOMNIA 13 0.0000
824 ERYTHEMA 10 0.0000
825 POLLAKIURIA 2 0.0000
826 DECREASED APPETITE 11 0.0000
827 BACK PAIN 11 0.0000
828 JOINT INJURY 1 0.0000
829 LIVER FUNCTION TEST INCREASED 1 0.0000
830 WEIGHT DECREASED 13 0.0000
831 DIARRHOEA 30 0.0000
832 HYPOACUSIS 2 0.0000
833 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
834 DEVICE LEAKAGE 2 0.0000
835 SWELLING FACE 3 0.0000
836 PRODUCT DOSE OMISSION 3 0.0000
837 PRODUCT PRESCRIBING ISSUE 1 0.0000
838 PERIPHERAL SWELLING 7 0.0000
839 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
840 HEPATOTOXICITY 1 0.0000
841 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
842 THROAT IRRITATION 2 0.0000
843 APPLICATION SITE PRURITUS 1 0.0000
844 SUICIDAL IDEATION 4 0.0000
845 CHEST PAIN 8 0.0000
846 RENAL DISORDER 2 0.0000
847 DYSPHAGIA 4 0.0000
848 DISEASE RECURRENCE 2 0.0000
849 SKIN BURNING SENSATION 3 0.0000
850 MOBILITY DECREASED 3 0.0000
851 MYALGIA 7 0.0000
852 BRONCHITIS 3 0.0000
853 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
854 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000
855 GASTRIC CANCER 1 0.0000
856 DRUG RESISTANCE 1 0.0000
857 OFF LABEL USE 34 0.0000
858 INFLAMMATION 2 0.0000
859 NO ADVERSE EVENT 7 0.0000
860 HAEMATOMA 1 0.0000
861 EXPOSURE VIA SKIN CONTACT 1 0.0000
862 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
863 ARTHRALGIA 16 0.0000
864 MUSCULOSKELETAL PAIN 2 0.0000
865 APPLICATION SITE ERYTHEMA 1 0.0000
866 MENSTRUATION IRREGULAR 1 0.0000
867 PAIN IN EXTREMITY 11 0.0000
868 THROMBOSIS 3 0.0000
869 FEAR 1 0.0000
870 RASH PRURITIC 2 0.0000
871 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
872 VISION BLURRED 5 0.0000
873 ABNORMAL DREAMS 1 0.0000
874 PROCEDURAL PAIN 1 0.0000
875 HAEMOPTYSIS 1 0.0000
876 ALOPECIA 7 0.0000
877 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
878 CEREBROVASCULAR ACCIDENT 6 0.0000
879 ANGINA PECTORIS 1 0.0000
880 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
881 ACUTE MYOCARDIAL INFARCTION 1 0.0000
882 WHEEZING 2 0.0000
883 ADVERSE DRUG REACTION 3 0.0000
884 OEDEMA PERIPHERAL 4 0.0000
885 VERTIGO 2 0.0000
886 BLOOD PRESSURE INCREASED 5 0.0000
887 DRUG ADMINISTRATION ERROR 1 0.0000
888 LIMB DISCOMFORT 1 0.0000
889 BONE DENSITY DECREASED 1 0.0000
890 HEAD INJURY 1 0.0000
891 MOVEMENT DISORDER 1 0.0000
892 DRUG INTOLERANCE 3 0.0000
893 DEPRESSION 7 0.0000
894 AMNESIA 2 0.0000
895 PSORIASIS 4 0.0000
896 PRODUCT DOSE OMISSION ISSUE 9 0.0000
897 CHOLELITHIASIS 1 0.0000
898 TREMOR 5 0.0000
899 DEHYDRATION 4 0.0000
900 ANGER 1 0.0000
901 SINUSITIS 3 0.0000
902 HAEMOGLOBIN DECREASED 3 0.0000
903 HYPERKALAEMIA 1 0.0000
904 INJURY 2 0.0000
905 HYPOXIA 1 0.0000
906 HYPERTENSION 6 0.0000
907 PRODUCT ADHESION ISSUE 1 0.0000
908 THERAPY INTERRUPTED 2 0.0000
909 OVERDOSE 6 0.0000
910 DRUG EFFECT INCOMPLETE 1 0.0000
911 THROMBOCYTOPENIA 3 0.0000
912 DYSARTHRIA 1 0.0000
913 UNEVALUABLE EVENT 2 0.0000
914 HOSPITALISATION 4 0.0000
915 SEIZURE 3 0.0000
916 PLASMA CELL MYELOMA 1 0.0000
917 ABNORMAL BEHAVIOUR 1 0.0000
918 DISORIENTATION 1 0.0000
919 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
920 DEVICE BREAKAGE 1 0.0000
921 BLINDNESS 1 0.0000
922 DRUG DOSE OMISSION 4 0.0000
923 RENAL IMPAIRMENT 2 0.0000
924 URINARY TRACT INFECTION 4 0.0000
925 HYPERHIDROSIS 3 0.0000
926 MUSCULOSKELETAL STIFFNESS 2 0.0000
927 COVID-19 4 0.0000
928 ANGIOEDEMA 1 0.0000
929 LIVER DISORDER 1 0.0000
930 DRY SKIN 3 0.0000
931 NEUTROPENIA 3 0.0000
932 CARDIAC DISORDER 2 0.0000
933 PRODUCT USE ISSUE 4 0.0000
934 FALL 7 0.0000
935 PRODUCTIVE COUGH 1 0.0000
936 LUNG DISORDER 1 0.0000
937 DRY EYE 1 0.0000
938 LEUKOPENIA 1 0.0000
939 CELLULITIS 1 0.0000
940 ACUTE KIDNEY INJURY 3 0.0000
941 PANCREATITIS 1 0.0000
942 DRUG EFFECT DECREASED 1 0.0000
943 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
944 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
945 ARTHROPATHY 1 0.0000
946 INFLUENZA 2 0.0000
947 SEPSIS 2 0.0000
948 BLISTER 1 0.0000
949 OXYGEN SATURATION DECREASED 1 0.0000
950 EYE PAIN 1 0.0000
951 RHEUMATOID ARTHRITIS 2 0.0000
952 CONVULSION 1 0.0000
953 HERPES ZOSTER 1 0.0000
954 LETHARGY 1 0.0000
955 PRODUCT SUBSTITUTION ISSUE 1 0.0000
956 NASAL CONGESTION 1 0.0000
957 EMOTIONAL DISTRESS 2 0.0000
958 NASOPHARYNGITIS 3 0.0000
959 VISUAL IMPAIRMENT 2 0.0000
960 GAIT DISTURBANCE 3 0.0000
961 INTENTIONAL OVERDOSE 1 0.0000
962 DEVICE EXPULSION 1 0.0000
963 BLOOD CREATININE INCREASED 1 0.0000
964 INFUSION RELATED REACTION 1 0.0000
965 FEBRILE NEUTROPENIA 1 0.0000
966 MEMORY IMPAIRMENT 2 0.0000
967 DYSGEUSIA 1 0.0000
968 CHRONIC KIDNEY DISEASE 1 0.0000
969 DRY MOUTH 1 0.0000
970 CARDIAC ARREST 1 0.0000
971 DRUG ABUSE 1 0.0000
972 BALANCE DISORDER 1 0.0000
973 INTENTIONAL PRODUCT MISUSE 1 0.0000
974 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
975 GASTROINTESTINAL DISORDER 1 0.0000
976 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
977 OROPHARYNGEAL PAIN 1 0.0000
978 COUGH 3 0.0000
979 BLOOD GLUCOSE INCREASED 2 0.0000
980 ATRIAL FIBRILLATION 1 0.0000
981 FLUSHING 1 0.0000
982 ILLNESS 1 0.0000
983 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
984 PNEUMONIA 3 0.0000
985 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
986 INFECTION 1 0.0000
987 MYOCARDIAL INFARCTION 1 0.0000
988 DEATH 1 0.0000